High-sensitive CRP (hs-CRP) was shown to be anindependent risk factor for MI, stroke, sudden death, andperipheral arterial disease in different prospectiveepidemiological studies and it can be decreased by statinsindependent of the LDL-level reductions [14–16]. This evidence concerns the gene CRP and stroke disorder.